Nectar Lifesciences Ltd

NSE: NECLIFE · BSE: 532649 · Pharmaceuticals & Biotechnology · 23 announcements

Share price: ₹10.59
Market cap: ₹237.5 Cr
Revenue (annual): ₹0.00 Cr
Net profit (annual): ₹-292.9 Cr
P/E (TTM): -1.0×Sector 47.3×
Promoter holding: 51.84%+0.00% QoQ
FII holding: 0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Management Change 4 Financial Results 4 Merger & Restructuring 3 Business Update 2 Board Meeting Date 2 Annual General Meeting 2 Legal & Regulatory 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

18 Sep 2026 12:25 IST NSE

Annual General Meeting

Nectar Lifesciences Annual General Meeting

Nectar Lifesciences filed proceedings of its 31st AGM held September 18, 2026. Resolutions covered adoption of FY26 financials and director re-appointments.

Read the filing ↗

14 Aug 2026 21:13 IST BSE

Annual General Meeting

Nectar Lifesciences Annual General Meeting

Nectar Lifesciences Ltd. has announced that its 31st Annual General Meeting will be held on September 18, 2026. The book closure period is set from September 12, 2026, to September 18, 2026.

Read the filing ↗